Pacira BioSciences (PCRX) EV to EBITDA (2015 - 2026)
Pacira BioSciences' EV to EBITDA was 7.23 in Q2 2026, up 21.5% from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) EV to EBITDA (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pacira BioSciences' EV to EBITDA was 0.69 through Jun 30, 2026; for FY2025, it came in at 7.49, down 89.5% from FY2024.
- In earlier years, EV to EBITDA was 71.40 in FY2024 (+803.8%), 7.90 in FY2023 (-19.4%), 9.80 in FY2022 (-43.0%) and 17.18 in FY2021 (-45.5%).
- Quarterly EV to EBITDA has moved between 5.50 (Q2 2024) and 71.40 (Q4 2024) over five years.
- Compared with a year earlier, EV to EBITDA was higher in two of the last four quarters, with growth averaging 196.2%.
- The best year-over-year quarter for EV to EBITDA over five years was Q4 2024 (growth of 803.8%); the worst was Q4 2025 (a decline of 89.5%).
- Per Business Quant data, PCRX's EV to EBITDA in the three quarters before Q2 2026 was 5.95 (Q1 2026), 7.49 (Q4 2025) and 6.50 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Pacira BioSciences | 1.43 Bn | 495.69 Mn | 148.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.07 |
| Mar 31, 2026 | 5.81 |
| Dec 31, 2025 | 7.29 |
| Sep 30, 2025 | 6.34 |
| Mar 31, 2025 | 1,919.64 |
| Dec 31, 2024 | 44.76 |
| Sep 30, 2024 | 16.22 |
| Jun 30, 2024 | 5.38 |
| Mar 31, 2024 | 5.68 |
| Dec 31, 2023 | 7.72 |
| Sep 30, 2023 | 8.75 |
| Jun 30, 2023 | 11.61 |
| Mar 31, 2023 | 12.66 |
| Dec 31, 2022 | 9.54 |
| Sep 30, 2022 | 13.46 |
| Jun 30, 2022 | 14.94 |
| Mar 31, 2022 | 19.88 |
| Dec 31, 2021 | 14.37 |
| Sep 30, 2021 | 12.17 |
| Jun 30, 2021 | 15.42 |
API Access
Pacira BioSciences EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();